Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jfm1330


T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Comparing Corporate Presentations

I disagree a bit on that. Sure they should pursue a phase II as soon as they...

August 1, 2022

T.TH

RE:RE:RE:RE:RE:Comparing Corporate Presentations

I pointed out many years ago that the patent situation was a weak spot in the...

July 30, 2022

T.TH

RE:RE:RE:RE:Trogarzo Press Release Today - No one?

The only advantage of intramuscular injection is that it is quicker. A nurse...

July 29, 2022

T.TH

RE:Will TH1902 extend life? Key question

PFS and parameters like that means nothing on a single patient. TH1902 wrote...

July 27, 2022

T.TH

RE:RE:RE:Th1902 and 5-FU resistance in colorectal cancer treatment

Total confusion here, TH1902 is not a cytotoxic aiming at sortilin. Docetaxel...

July 27, 2022

T.TH

RE:RE:All comers dose and safety vs targeting high sortlin express

Two things. They do a trial on a targeted drug, but relying on target...

July 27, 2022

T.TH

RE:RE:RE:RE:REALITY is the STOCK is DEAD until

The best case scenario is obviously an indication with very good early...

July 26, 2022

T.TH

RE:1b results?

On clinicaltrials.gov the estimated study completion date is March 2023, but...

July 26, 2022

T.TH

RE:RE:REALITY is the STOCK is DEAD until

I am at the point that an added reason for me to see a really good news would...

July 26, 2022

T.TH

RE:RE:RE:RE:Morning after thoughts on Lafond s sale of stock

You put it as a joke, but it's not. These V-P are there for the pay first...

July 26, 2022

T.TH

RE:RE:I spoke with LaFond this morning

I am sure Lafond says to himself, I don't understand much about this...

July 25, 2022

T.TH

RE:I spoke with LaFond this morning

I remember a former V-P, Pirazelli, he sold a lot of shares around 2.00...

July 25, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Exercise of Options

The other thing, at an exercise price of 0.38$, these were probably options...

July 25, 2022

T.TH

RE:RE:RE:RE:RE:RE:Exercise of Options

Lafond did the same a few years ago and there was the same resentment towards...

July 25, 2022

T.TH

RE:RE:RE:RE:Canadian technology

Talking about Canadian technology against cancer, look at this. An incredible...

July 24, 2022

T.TH

RE:IMMU type buyout takes us to $220/share

One thing I thought and wonder about when we do the comparison with...

July 23, 2022

T.TH

RE:RE:RE:Canadian technology

Just to give an idea. We talk about PDCs here and a PDC includes a peptide as...

July 23, 2022

T.TH

RE:RE:Canadian technology

The quantity is not a problem. TH1902 has 2 linkers + 2 docetaxel molecules...

July 23, 2022

T.TH

Canadian technology

We had an ignorant here not so long ago complaining about Thera being a...

July 23, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:POC

I agree that in phase Ia it was hard to get biopsies and so on, but I gave...

July 21, 2022

Featured Company